Skip to content ↓

Hayward R. Alker, alum and former professor

Hayward R. Alker, an MIT alumnus and political scientist specializing in international relations, died Aug. 24 at his home in Block Island, R.I., following a cerebral hemorrhage. He was 69.

A New York City native, Alker was a leading scholar on international conflict resolution, widely respected for his integration of mathematical and humanistic research methods. His books include "Journeys Through Conflict" (2001) and "Mathematics and Politics" (1965).

Alker taught at MIT from 1968 to 1995, when he left to teach at the University of Southern California, where he held the John A. McCone Chair in International Relations.

He earned an S.B. in mathematics from MIT in 1959 and his M.A. and Ph.D. degrees from Yale University in 1960 and 1963, respectively. He taught at Yale before he came to MIT.

Alker is survived by his wife, J. Ann Tickner, of Santa Monica, Calif.; his brother, Henry; his sister, Charity; three daughters, Joan, Heather and Gwendolyn; and six grandchildren. In lieu of flowers, contributions may be made to the Middle East Peace Education Program of the American Friends Service Committee in Los Angeles or to the Block Island Conservancy.

A version of this article appeared in MIT Tech Talk on September 19, 2007 (download PDF).

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story